Tudor Investment Corp
LSTA icon

Tudor Investment Corp’s Lisata Therapeutics LSTA Stock Holding History

Tudor Investment Corp’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-183
Closed -$16K – 1595
2016
Q2 		$16K Hold
183
– – ﹤0.01% 1574
2016
Q1 		$21K Hold
183
– – ﹤0.01% 1681
2015
Q4 		$30K Hold
183
– – ﹤0.01% 1596
2015
Q3 		$41K Hold
183
– – ﹤0.01% 1483
2015
Q2 		$51K Buy
+183
New +$68K ﹤0.01% 1442

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Tudor Investment Corp's LSTA Position: Q3 2016 in Review

Tudor Investment Corp sold out of Lisata Therapeutics (LSTA) in Q3 2016, closing a stake of 183 shares — an estimated $16K sold.

Tudor Investment Corp first reported a position in LSTA in Q2 2015 and held it in 5 quarters. The position peaked at $51K in Q2 2015. 28 funds tracked by Wall St. Rank hold LSTA as of Q3 2016.

  • Tudor Investment Corp reported no remaining Lisata Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Tudor Investment Corp sold 183 Lisata Therapeutics shares in Q3 2016, an estimated $16K.
  • Tudor Investment Corp first reported a position in Lisata Therapeutics in Q2 2015 and held it in 5 quarters.
  • Tudor Investment Corp's Lisata Therapeutics position peaked at $51K in Q2 2015.
  • 28 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2016.

Based on Tudor Investment Corp's 13F filing for Q3 2016, filed 14 Nov 2016.